Optiscan unveils ‘digital pathology workhorse’
Optiscan unveils InForm, its ‘revolutionary digital pathology workhorse’, poised to challenge traditional analogue workflows and accelerate diagnosis.
Optiscan unveils InForm, its ‘revolutionary digital pathology workhorse’, poised to challenge traditional analogue workflows and accelerate diagnosis.
Wellnex receives conditional binding commitments of $14.3 million to reach estimated capital requirements for London Stock Exchange listing.
Three of Australia’s most successful global life sciences plays have reported increased interim profits – with the promise of more for the current half.
The ASX has dropped again with banks and miners hit. Aussie jobs stay strong at 4.1%, and Wesfarmers and Megaport have led earnings.
The Middle East healthcare sector is undergoing rapid expansion presenting opportunities for ASX-listed companies.
While lithium-ion batteries continue to dominate energy storage, alternative battery technologies are starting to gain traction.
China’s export controls on critical mineral tungsten could mean higher prices for the commodity and healthy market conditions for ASX companies.
Imugene’s trial programs could result in the first ‘off the shelf’ Car-T therapy that uses healthy donors’ cells.
Good morning! Here’s everything you need to know before the ASX opens today.
Investors have gorged on Labyrinth Resources shares this morning with mining identities Alex Hewlett and Kelvin Flynn vending the historic Vivien gold mine into the explorer.
Local markets were up this morning, following another fabulous night in New York.
Spartan and CEO Simon Lawson prove doubters of Dalgaranga wrong with massive high grade resource upgrade for Never Never discovery.
Gold topped July’s podium, followed closely behind by lithium and copper.
Paterson Province a flurry as Antipa nets $17m on sale of Citadel to Rio, while Labyrinth finds 7.8g/t gold and Tesoro ends dispute.
Original URL: https://www.heraldsun.com.au/business/stockhead/page/6